Another Tool in the Toolbelt: Adding Tirzepatide to OSA Treatment

Description

his webinar is a collaboration between the American Academy of Sleep Medicine (AASM) and the Obesity Medicine Association (OMA). We’ll explore whether tirzepatide’s benefits go beyond weight loss, how to prescribe and monitor it and discuss insurance coverage, including Medicare. Key topics include patient selection, contraindications, follow-up strategies, and the role of direct-to-consumer programs. This session is essential for healthcare providers managing OSA and obesity.

Objectives

Upon completion of this activity, participants should be able to:

Understand the key findings and conclusions of the SURMOUNT-OSA trial.
Assess the role of tirzepatide in improving OSA outcomes, beyond weight loss.
Learn the criteria for prescribing tirzepatide and its clinical use in managing OSA.
Navigate insurance coverage for tirzepatide and better understand the approval process.
Develop strategies for ongoing patient monitoring and follow-up after initiating tirzepatide.

Summary


Availability:	On-Demand
	Expires on Feb 17, 2028


Credit Offered:	No Credit Offered


Contains:	Course